LIQUIDIA CORPORATION Long-Term Debt
LIQUIDIA CORPORATION (LQDA) had Long-Term Debt of $19.88 million as of 2022-12-31, per its 10-K filed 2024-03-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2024-03-13
- 2022-12-31: Long-term Debt, Excluding Current Maturities $19.88M.
- 2022-09-30: Long-term Debt, Excluding Current Maturities $19.74M.
- 2022-06-30: Long-term Debt, Excluding Current Maturities $19.61M.
- 2022-03-31: Long-term Debt, Excluding Current Maturities $19.48M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2022-12-31 | $19.88M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $19.74M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $19.61M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $19.48M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $10.41M 10-K · filed 2023-03-20 | $10.41M 10-K · filed 2022-03-17 |
| 2021-09-30 | $10.33M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $10.25M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $10.18M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $10.29M 10-K · filed 2022-03-17 | |
| 2019-12-31 | $10.29M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |